Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 5Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1

Conditions

Neoplasms 3Ovarian Neoplasms 2Hematopoietic and Lymphatic System Neoplasm 2Hematologic Neoplasms 2Weight Cycling 1Tobacco Use Disorder 1Tobacco Use Cessation 1Substance-Related Disorders 1Smoldering Multiple Myeloma 1Prostatic Neoplasms 1Polycystic Ovary Syndrome 1Multiple Myeloma 1Motor Activity 1Mental Disorders 1Lung Neoplasms 1Insulin Resistance 1Hematopoietic and Lymphoid System Neoplasm 1Fallopian Tube Neoplasms 1Endometrial Neoplasms 1Brain Neoplasms 1Anatomic Stage I Breast Cancer AJCC v8 1

Interventions

Dexamethasone 87daratumumab 49Lenalidomide 49pomalidomide 33Bortezomib 32Cyclophosphamide 31carfilzomib 25Calcium Dobesilate 21talquetamab 19fludarabine 18isatuximab 16iberdomide 16Magnetic Resonance Spectroscopy 16Specimen Handling 15Biopsy 14selinexor 12Melphalan 11belantamab mafodotin 10dexamethasone acetate 9dexamethasone 21-phosphate 8elotuzumab 7auricularum 7venetoclax 6tocilizumab 5fludarabine phosphate 5X-Rays 5Blood Specimen Collection 5ruxolitinib 4Methylprednisolone 4Injections 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Multiple Myeloma × Behavior Therapy × Clear all
NCT05312255 2025-12-01

Non-chemotherapeutic Interventions for the Improvement of Quality of Life and Immune Function in Patients With Multiple Myeloma

Roswell Park Cancer Institute

Phase NA Recruiting
175 enrolled
Plasma cell

Smoldering Multiple Myeloma, Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡